HK1105451A1 - Methods for antibody library screening - Google Patents

Methods for antibody library screening

Info

Publication number
HK1105451A1
HK1105451A1 HK07113709.8A HK07113709A HK1105451A1 HK 1105451 A1 HK1105451 A1 HK 1105451A1 HK 07113709 A HK07113709 A HK 07113709A HK 1105451 A1 HK1105451 A1 HK 1105451A1
Authority
HK
Hong Kong
Prior art keywords
methods
antibody library
library screening
screening
antibody
Prior art date
Application number
HK07113709.8A
Other languages
English (en)
Inventor
Marike Josee Janneke Gertrud Stassar
Herald Reiersen
Original Assignee
Affitech Res As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0422433A external-priority patent/GB0422433D0/en
Priority claimed from GBGB0422431.7A external-priority patent/GB0422431D0/en
Application filed by Affitech Res As filed Critical Affitech Res As
Publication of HK1105451A1 publication Critical patent/HK1105451A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Transplantation (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Psychiatry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK07113709.8A 2004-10-08 2007-12-17 Methods for antibody library screening HK1105451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0422433A GB0422433D0 (en) 2004-10-08 2004-10-08 Method
GBGB0422431.7A GB0422431D0 (en) 2004-10-08 2004-10-08 Method
PCT/GB2005/003865 WO2006038021A1 (fr) 2004-10-08 2005-10-07 Procede de criblage d'une banque d'anticorps

Publications (1)

Publication Number Publication Date
HK1105451A1 true HK1105451A1 (en) 2008-02-15

Family

ID=35426982

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113709.8A HK1105451A1 (en) 2004-10-08 2007-12-17 Methods for antibody library screening

Country Status (9)

Country Link
US (1) US20080300140A1 (fr)
EP (1) EP1802980B1 (fr)
JP (1) JP4729043B2 (fr)
AU (1) AU2005291011B2 (fr)
CA (1) CA2579937C (fr)
DK (1) DK1802980T3 (fr)
HK (1) HK1105451A1 (fr)
IL (1) IL181928A (fr)
WO (1) WO2006038021A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2496659A1 (fr) * 2009-11-05 2012-09-12 IFP Energies nouvelles Fluide d'injection et procede de recuperation assistee de petrole
CA2887933A1 (fr) * 2012-10-12 2014-04-17 Arizona Board Of Agents, On Behalf Of Arizona State University Reactifs a base d'anticorps qui reconnaissent specifiquement des formes oligomeriques toxiques de tau
US20190144937A1 (en) * 2016-04-29 2019-05-16 The Regents Of The University Of California Novel methods for quantifying proteins using phage-based sequencing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565332A (en) * 1991-09-23 1996-10-15 Medical Research Council Production of chimeric antibodies - a combinatorial approach
US6589736B1 (en) * 1994-11-22 2003-07-08 The Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
US6699658B1 (en) * 1996-05-31 2004-03-02 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5985543A (en) * 1996-10-11 1999-11-16 The Trustees Of The University Of Pennsylvania Compositions and methods for detection of antibody binding to cells
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method
US7420030B2 (en) * 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US20040175756A1 (en) * 2001-04-26 2004-09-09 Avidia Research Institute Methods for using combinatorial libraries of monomer domains
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US7244592B2 (en) * 2002-03-07 2007-07-17 Dyax Corp. Ligand screening and discovery
WO2004056995A1 (fr) * 2002-12-23 2004-07-08 Affitech As Procede de production d'une banque d'expression de peptide in vitro
JP4809767B2 (ja) * 2003-08-18 2011-11-09 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 発現ベクター、ポリペプチドディスプレイライブラリ、並びにそれらの作製及び使用方法

Also Published As

Publication number Publication date
CA2579937C (fr) 2013-07-02
DK1802980T3 (da) 2013-03-04
CA2579937A1 (fr) 2006-04-13
WO2006038021A1 (fr) 2006-04-13
EP1802980A1 (fr) 2007-07-04
US20080300140A1 (en) 2008-12-04
EP1802980B1 (fr) 2012-12-05
AU2005291011B2 (en) 2011-10-13
IL181928A0 (en) 2007-07-04
AU2005291011A1 (en) 2006-04-13
JP4729043B2 (ja) 2011-07-20
JP2008515419A (ja) 2008-05-15
IL181928A (en) 2011-11-30

Similar Documents

Publication Publication Date Title
EP1848672A4 (fr) Banques et methodes permettant d'isoler des anticorps
IL178409A0 (en) Humanized anti-tgf-beta antibodies
SG10201404801YA (en) Monoclonal antibody
IL181575A0 (en) Anti-ox40l antibodies
IL228033A0 (en) Antibodies
IL180852A0 (en) Anti-cd154 antibodies
EP1761566A4 (fr) Anticorps monoclonaux humanises anti-tag-72
EP1860120A4 (fr) Procédé permettant d'améliorer un anticorps
EP1743945A4 (fr) Procédé de criblage
GB0420466D0 (en) Anti-glucan antibodies
EP1718749A4 (fr) Anticorps monoclonal anti af-20 humanise
IL206072A0 (en) Novel method for generating and screening an antibody library
GB0514678D0 (en) Method for high-throughput screening
EP1860185A4 (fr) Procédé de criblage
EP1721971A4 (fr) Procede de test de selection
ZA200701952B (en) Anti-OX40L antibodies
EP1857817A4 (fr) Procédé de criblage
HK1105451A1 (en) Methods for antibody library screening
IL215527A (en) Methods will notice training
EP1780221A4 (fr) Anticorps anti-synovioline
EP1712564A4 (fr) Anticorps monoclonal anti-nc1
GB0415644D0 (en) Monoclonal antibody
GB0418415D0 (en) Antibody
GB0414810D0 (en) Methods for identifying antibodies
GB0420771D0 (en) Antibody

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161007